Early experience of delamanid in extensively drug-resistant pulmonary tuberculosis

被引：1
|
作者：
Marwah, Vikas [1 ]
Patil, Prashant R. [2 ]
Choudhary, Robin [1 ]
Malik, Virender [3 ]
机构：
[1] Army Inst Cardiothorac Sci, Dept Pulm Crit Care & Sleep Med, Pune, Maharashtra, India
[2] Army Inst Cardiothorac Sci, Dept Pathol, Pune, Maharashtra, India
[3] Army Inst Cardiothorac Sci, Dept Radiol, Pune, Maharashtra, India
来源：
LUNG INDIA | 2023年 / 40卷 / 01期
关键词：
Delamanid; extensively drug-resistant tuberculosis; sputum smear positive pulmonary tuberculosis; OUTCOMES;
D O I：
10.4103/lungindia.lungindia_451_22
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Tuberculosis is a leading cause of death in our country. Multidrug-resistant tuberculosis increases the morbidity and mortality due to severe manifestations and difficult and prolonged medications. Newer antitubercular drugs like delamanid have been approved by WHO in management of these cases, but the real-world experience of this drug is lacking in our country. We present our early experience of use of delamanid in extensively drug-resistant pulmonary tuberculosis.
引用
收藏
页码：75 / 78
页数：4
相关论文
共 50 条
  • [1] Delamanid for Extensively Drug-Resistant Tuberculosis
    Gupta, Rajesh
    Geiter, Lawrence J.
    Wells, Charles D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03): : 291 - 292
  • [2] Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
    Maryandyshev, Andrey
    Pontali, Emanuele
    Tiberi, Simon
    Akkerman, Onno
    Ganatra, Shashank
    Sadutshang, Tsetan Dorji
    Alffenaar, Jan-Willem
    Amale, Rohit
    Mullerpattan, Jai
    Topgyal, Sonam
    Udwadia, Zarir Farokh
    Centis, Rosella
    D'Ambrosio, Lia
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    [J]. EMERGING INFECTIOUS DISEASES, 2017, 23 (10) : 1718 - 1721
  • [3] Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis
    Kliiman, Kai
    Altraja, Alan
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (11) : 766 - W137
  • [4] First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
    Tadolini, Marina
    Lingtsang, Rangjung Dolma
    Tiberi, Simon
    Enwerem, Martin
    D'Ambrosio, Lia
    Sadutshang, Tsetan Dorji
    Centis, Rosella
    Migliori, Giovanni Battista
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 935 - 938
  • [5] Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Children: The Role of Bedaquiline and Delamanid
    Pecora, Francesco
    Dal Canto, Giulia
    Veronese, Piero
    Esposito, Susanna
    [J]. MICROORGANISMS, 2021, 9 (05)
  • [6] Extensively drug-resistant tuberculosis
    LoBue, Philip
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2009, 22 (02) : 167 - 173
  • [7] Extensively Drug-Resistant Tuberculosis
    Dheda, Keertan
    Shean, Karen
    Badri, Motasim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (22): : 2390 - 2390
  • [8] Extensively drug-resistant tuberculosis
    Jassal, Mandeep
    Bishai, William R.
    [J]. LANCET INFECTIOUS DISEASES, 2009, 9 (01): : 19 - 30
  • [9] Bedaquiline, Delamanid, Linezolid, and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis
    Padmapriyadarsini, Chandrasekaran
    Vohra, Vikram
    Bhatnagar, Anuj
    Solanki, Rajesh
    Sridhar, Rathinam
    Anande, Lalitkumar
    Muthuvijaylakshmi, M.
    Bhatia, Miraa
    Jeyadeepa, Bharathi
    Taneja, Gaurav
    Balaji, S.
    Shah, Prashant
    Saravanan, N.
    Chauhan, Vijay
    Kumar, Hemanth
    Ponnuraja, Chinnayin
    Livchits, Viktoriya
    Bahl, Monica
    Alavadi, Umesh
    Sachdeva, K. S.
    Swaminathan, Soumya
    [J]. CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E938 - E946
  • [10] Extensively drug-resistant tuberculosis
    Todd, Betsy
    [J]. AMERICAN JOURNAL OF NURSING, 2007, 107 (06) : 29 - 31
12345